Broomfield, Colorado-based Accera has raised $7.5M in a Series B round, the firm said Wednesday. Accera is developing drugs focused on treating Alzheimer’s disease and related neurodegenerative diseases. Funding was led by Inventages Venture Capital SA, and also included POSCO BioVentures and other investors.
